PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-18.58%
Negative revenue growth while OBE stands at 4.29%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-40.04%
Negative gross profit growth while OBE is at 5.29%. Joel Greenblatt would examine cost competitiveness or demand decline.
-37.43%
Negative EBIT growth while OBE is at 3.65%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-37.43%
Negative operating income growth while OBE is at 10.58%. Joel Greenblatt would press for urgent turnaround measures.
46.26%
Net income growth at 75-90% of OBE's 52.70%. Bill Ackman would press for improvements to catch or surpass competitor performance.
49.37%
EPS growth similar to OBE's 52.27%. Walter Schloss would assume both have parallel share structures and profit trends.
49.94%
Similar diluted EPS growth to OBE's 50.57%. Walter Schloss might see standard sector or cyclical influences on both firms.
-16.13%
Share reduction while OBE is at 1.41%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-16.23%
Reduced diluted shares while OBE is at 1.75%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
52.63%
Dividend growth above 1.5x OBE's 5.21%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
1.12%
OCF growth under 50% of OBE's 5.30%. Michael Burry might suspect questionable revenue recognition or rising costs.
25.48%
FCF growth under 50% of OBE's 127.16%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
139.84%
10Y revenue/share CAGR above 1.5x OBE's 4.23%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
139.84%
5Y revenue/share CAGR above 1.5x OBE's 4.23%. David Dodd would look for consistent product or market expansions fueling outperformance.
152.42%
3Y revenue/share CAGR above 1.5x OBE's 4.23%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
467.41%
OCF/share CAGR of 467.41% while OBE is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
467.41%
OCF/share CAGR of 467.41% while OBE is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
195.65%
3Y OCF/share CAGR of 195.65% while OBE is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
697.91%
Net income/share CAGR above 1.5x OBE's 260.88% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
697.91%
5Y net income/share CAGR above 1.5x OBE's 260.88%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
332.86%
3Y net income/share CAGR 1.25-1.5x OBE's 260.88%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
135.21%
10Y equity/share CAGR at 75-90% of OBE's 160.40%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
135.21%
5Y equity/share CAGR at 75-90% of OBE's 160.40%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
149.39%
3Y equity/share CAGR similar to OBE's 160.40%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
146.65%
Dividend/share CAGR of 146.65% while OBE is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
146.65%
Dividend/share CAGR of 146.65% while OBE is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
173.31%
3Y dividend/share CAGR of 173.31% while OBE is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-3.17%
Firm’s AR is declining while OBE shows 19.98%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
21.05%
Inventory growth of 21.05% while OBE is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
4.76%
Asset growth well under 50% of OBE's 99.61%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
29.82%
Under 50% of OBE's 139.90%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-1.07%
We’re deleveraging while OBE stands at 109.19%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-89.96%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.